FSI, a private equity firm, completed the acquisition of a 35% stake in Sterling, a company that produces active pharmaceutical ingredients. Financial terms were not disclosed. “The purpose of this partnership is to participate in the necessary evolution of a fundamental sector for Italy. The alliance with FSI was designed to equip Sterling with an important financial asset and allow it to acquire strategic resources with the aim of implementing the development plan envisaged by the Company for the next five years. With this transaction, Sterling intends to confirm its desire to fuel the development of the pharmaceutical sector in the territory and increase its position as an international reference," Simone Ferlin, Sterling Chairman and CEO.